---
title: "Repligen’s deal for BioLife Solutions indicates shift to manufacturing integration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295825876.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-08-13T10:20:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295825876.md)
  - [en](https://longbridge.com/en/news/295825876.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295825876.md)
generator: "portal-rs"
---

# Repligen’s deal for BioLife Solutions indicates shift to manufacturing integration

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [BLFS.US](https://longbridge.com/en/quote/BLFS.US.md)
- [RGEN.US](https://longbridge.com/en/quote/RGEN.US.md)

## Related News & Research

- [BioLife Solutions Sets October Vote on Cash‑and‑Stock Merger With Repligen](https://longbridge.com/en/news/298079129.md)
- [Repligen (RGEN) Dropped, So What Is Behind The Latest Attention?](https://longbridge.com/en/news/297396535.md)
- [Apogee Enterprises to acquire GroGlass for up to €62.5M](https://longbridge.com/en/news/297827400.md)
- [Firefox for iOS Gets Built-In Ad Blocker](https://longbridge.com/en/news/297656638.md)
- [Peptide innovator says the drug class is due for a rethink](https://longbridge.com/en/news/297803292.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**